Indoco Remedies Limited (INDOCO) fair value: what the stock is really worth
As of Nov 16, 2026: fair value (intrinsic value) of Indoco Remedies Limited stock ₹101, price ₹227, that is 55.7% below the price, quality 37 out of 100. Rating: strongly overvalued. Calculated from audited financials with 2 of our 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Indoco Remedies Limited
INDOCO · NSEFar too expensive (fair value 56% below the price), weak company and price moving sideways: meets none of the 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 11, 2026.
How to read this chart
60‑month range ₹163.86 – ₹508.75 · fair‑value band ₹46.88 – ₹154.55 · the ₹227.14 price screens above the ₹100.71 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 11, 2026.
Every Wednesday you see whether Indoco Remedies is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Indoco Remedies Limited manufactures and markets formulations and active pharmaceutical ingredients in India and internationally.
Show moreShow less
It offers products for gastrointestinal, anti-infectives, respiratory, stomatological, vitamins/minerals/nutrients, urological, ophthal/ontological, dermatology, pain/analgesic, cardiac, anti-diabetic, and gynaecological therapeutic areas.
The company also provides branded generics comprising analgesic tablets and topical preparations; anti-hypertensive; protein supplements; multivitamin tablets and syrups; antibiotic tablets, syrups, and injectables; oral rehydration powders; antacids; and antihistaminic, anti-inflammatory drugs, etc.
In addition, it provides analytical services, such as impurity profile, particle size analysis, polymorphism and compatibility studies, heavy metal analysis, extractables and leachables studies, lyophilization studies, reference and working standards, forced degradation studies, and chromatographic method development and validation services.
Further, the company offers architectural design, lighting, mechanical and utility engineering, project and construction management, electrical, control system, piping, structural design, data transfer system, and process engineering.
Additionally, it provides contract research services, such as custom chemical synthesis of molecules and intermediates; process chemistry research and development; non-infringing process designing and scale up; and analytical method development, validation, impurity characterization, and polymorphic studies, solutions, as well as intellectual property management.
The company was formerly known as Indo Continental Trading Company. Indoco Remedies Limited was founded in 1945 and is based in Mumbai, India.
Stock analysis
Indoco Remedies Limited (INDOCO) currently trades at ₹227.14, while our model-based Fair Value estimate is ₹100.71, 56% below the price, so the stock looks overvalued today.
Show more
Valuation
How firm this estimate is: it rests on 2 models at a data quality of 96/100, which puts the data coverage at medium.
Scenario range: ₹46.88 (bear) to ₹154.55 (bull), the price of ₹227.14 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 37/100 (below-average quality), in the Healthcare sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Indoco Remedies Limited reported revenue of ₹18.5B in FY2026 versus ₹15.0B in FY2022, a compound +5.3%/yr. Reported net income was −₹987M in FY2026.
Key figures
Market cap ₹20.2B (≈ $215M) Micro · P/E ratio 66.0 · P/S ratio 1.06 · EPS (TTM) ₹3.44 · Dividend yield 0.1% · Net margin 1.7% · Return on equity 3.2% · Return on assets (EBIT) 6.5% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 20 out of 100 (low confidence).
What moves the price
The share trades about 17% below its 52-week high and 39% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −27% fair-value upside, at −56%, INDOCO screens richer than that median.
Fair Value models
All 2 models by family
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
INDOCO screens overvalued: fair value 56% below the price. Compare with Merck KGaA →
Compare Indoco Remedies Limited with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Drug Manufacturers - Specialty & Generic · 604 stocks
Valuation Multiplesvs Drug Manufacturers - Specialty & Generic median · lower = cheaper
Strength profile in five axes (Snowflake)
VALUE 0: the price sits above our fair-value range.
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Fair value gap by industry
- Return on assets by industry
- Stock screener with 62 metrics
- Undervalued stocks: Indian Stocks
- Valuation of the India market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Zoetis Inc ZTS | $84.39 | $113.53 | +35% | vs INDOCO |
| Jiangsu Hengrui Pharmaceuticals Co 600276 | ¥48.02 | ¥53.04 | +10% | vs INDOCO |
| Sun Pharmaceutical Industries Limited SUNPHARMA | ₹1,868 | ₹1,983 | +6% | vs INDOCO |
| Haleon plc HLN | $9.20 | $8.47 | −8% | vs INDOCO |
| Merck KGaA MRK | €149.70 | €108.83 | −27% | vs INDOCO |
| Galderma Group GALD | CHF 191.00 | CHF 112.46 | −41% | vs INDOCO |
| Takeda Pharmaceutical Company TAK | $21.59 | $11.23 | −48% | vs INDOCO |
| Teva Pharmaceutical Industries Limited TEVA | $42.57 | $20.74 | −51% | vs INDOCO |
| Sandoz Group SDZ | CHF 84.60 | CHF 40.54 | −52% | vs INDOCO |
| Divi's Laboratories Limited DIVISLAB | ₹11,080 | ₹1,567 | −86% | vs INDOCO |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Indoco Remedies Limited (INDOCO) overvalued or undervalued?
What is the fair value of INDOCO?
What is the quality score of INDOCO?
What is the price target for Indoco Remedies Limited (INDOCO)?
What is the Indoco Remedies Limited stock forecast for 2026?
What is the revenue of Indoco Remedies Limited (INDOCO)?
Does Indoco Remedies Limited pay a dividend?
How much is the dividend of Indoco Remedies Limited (INDOCO) and when is the ex-dividend date?
What is the intrinsic value of Indoco Remedies Limited (INDOCO)?
Is Indoco Remedies Limited stock overvalued or undervalued in 2026?
Is fair value the same as the market price of INDOCO?
How much is Indoco Remedies Limited worth?
What do the bullish and bearish scenarios say about INDOCO?
What is the P/E ratio of INDOCO?
How solid is the balance sheet of Indoco Remedies Limited (INDOCO)?
How far is INDOCO from its 52-week high?
Which stocks are comparable to Indoco Remedies Limited?
Is Indoco Remedies Limited stock attractive at the current price?
How is the fair value of INDOCO calculated?
Is it still worth investing in stocks now?
What is the share price of Indoco Remedies Limited (INDOCO)?
What should I pay attention to with Indoco Remedies Limited right now?
Key figures of Indoco Remedies Limited
How large is the market capitalisation of Indoco Remedies Limited (INDOCO)?
What is the P/S ratio of Indoco Remedies Limited (INDOCO)?
What are the earnings per share of Indoco Remedies Limited (INDOCO)?
What is the dividend yield of Indoco Remedies Limited (INDOCO)?
What is the net margin of Indoco Remedies Limited (INDOCO)?
What is the return on equity of Indoco Remedies Limited (INDOCO)?
What is the EBIT return on assets of Indoco Remedies Limited (INDOCO)?
What is the operating margin of Indoco Remedies Limited (INDOCO)?
How fast is revenue growing at Indoco Remedies Limited (INDOCO)?
How fast are earnings growing at Indoco Remedies Limited (INDOCO)?
How much free cash flow does Indoco Remedies Limited (INDOCO) generate?
How much net debt does Indoco Remedies Limited (INDOCO) carry?
Watch Indoco Remedies Limited in the live analysis
One click puts Indoco Remedies Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.